XML 113 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Income taxes
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income taxes
17.
Income taxes:
The components of loss before income taxes consist of the following:
 
                    2019                  2018                  2017 
Canadian
    $(12,667   $5,015    $(14,841
Foreign
       (22,338  (21,556  (14,607
Loss before income taxes
    $(35,005   $    (16,541   $    (29,448
The reconciliation of income tax computed at statutory tax rates to income tax expense, using a 27.0% (2018 – 27.0%; 2017 – 26.0%) statutory tax rate, is:
 
    December 31,
2019
  December 31,
2018
  December 31,
2017
 
Loss before income taxes
    $(35,005   $(16,541   $(29,448
Statutory tax rate
   27.0%   27.0%   26.0% 
Income tax recovery at Canadian statutory income tax rates
    $(9,451   $(4,466   $(7,656
Change in valuation allowance
   11,576   (87,082  1,625 
Disposal of Canadian Operations (notes 1 and 9)
   -   81,690   - 
Permanent differences
   808   875   967 
Expiry of investment tax credits and
non-capital
losses
   1,589   5,838   1,243 
Tax rate differences
   613   748   790 
Change in U.S. statutory rate
   -   -   6,394 
Change in Canadian statutory rate
   -   -   (2,595
Adjustments related to prior periods
   (4,956  2,167   (417
Other differences
   -   268   12 
Income tax expense
    $179    $38    $363 
 
As a result of tax legislation enacted in the U.S. at the end of 2017, the federal U.S. corporate tax rate applicable to years subsequent to 2017 was substantially reduced. The Company recorded a deferred income tax expense in respect of its U.S. operations in 2017 using the new federal rate of 21%; however, there was no impact on tax expense as a valuation allowance is provided on most of these deferred tax assets.
The Company also revalued its deferred tax assets in respect of its Canadian operations to reflect the increase in the Canadian corporate income tax rate to 27% for years subsequent to 2017. There was no impact on tax expense as a full valuation allowance is provided on these deferred tax assets.
Significant components of the Company’s deferred tax assets are shown below:
 
    
December 31,
2019
   
December 31,
2018
 
Deferred tax assets:
    
Tax loss carryforwards
  $38,173   $27,226 
Tax values of depreciable assets in excess of accounting values
   481    69 
Share issue costs and other
   637    486 
Total deferred tax assets
   39,291    27,781 
Valuation allowance
   (38,991)    (27,398) 
Net deferred tax assets
  $300   $383 
The Company also has total loss carryforwards of $162,080 (December 31, 2018 - $118,373) available to offset future taxable income: in Canada, in the amount of $12,352 (December 31, 2018 - $2,580); in Switzerland, in the amount of $106,838 (December 31, 2018 - $70,647); in the United States, in the amount of $42,525 (December 31, 2018 - $44,679); and in the United Kingdom, in the amount of $365 (December 31, 2018 - $467). The loss carryforwards expire between 2020 and 2039, except for the United Kingdom. The loss carryforwards in the United Kingdom do not expire.
The Company’s
non-capital
losses for income tax purposes expire as follows:
 
    
  Non-capital

losses
 
2020
  $18,167 
2021
   16,932 
2022
   20,552 
2023
   16,820 
2024
   25,657 
Thereafter until 2038
   63,952 
   $162,080 
 
The Company recognizes interest and penalties related to income taxes in interest and other income. To date, the Company has not incurred any significant interest and penalties. The Company is subject to assessments by various taxation authorities which may interpret tax legislations and tax filing positions differently from the Company. The Company provides for such differences when it is likely that a taxation authority will not sustain the Company’s filing position and the amount of the tax exposure can be reasonably estimated. As at December 31, 2019, a provision of nil (December 31, 2018 - nil) has been made in the financial statements for estimated tax liabilities. Tax years ranging from 2011 to 2019 remain subject to examination in the various countries we operate in.